The major players in the urinary tract infection treatment market include AstraZeneca, Bayer AG, Cipla, Inc., GlaxoSmithKline PLC, Merlion Pharma, Novartis AG and Pfizer. The increasing prevalence of diabetes and kidney stones is primarily driving the market growth. The development of new combination drugs for the treatment of UTI is again accelerating market growth. However, lack of awareness in developing and underdeveloped economies is likely to hamper the market growth. Whereas, the increasing recurrence rate for UTIs is expected to augment the demand for treatment over the forecast period.
The entire urinary tract infection treatment market has been sub-categorized into drug, and indication. current and future demand for urinary tract infection treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
By Drug
- Penicillin & Combinations
- Quinolones
- Cephalosporin
- Azoles & Amphotericin B
- Nitrofurans
- Others
By Indication
- Complicated UTI
- Uncomplicated UTI
- Others
Source: https://www.valuemarketresearch.com/report/urinary-tract-infection-treatment-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.